Previous transgenic mouse studies have revealed that such upregulation of peripherin in context of NfL reduction can trigger motor neuron degeneration with ALS-like phenotypes and axonal transport defects [2, 42]. This evidence concerns the gene NEFL and amyotrophic lateral sclerosis.